CA Stock MarketDetailed Quotes
RVV Revive Therapeutics Ltd
- 0.005
- -0.005-50.00%
15min DelayMarket Closed Dec 13 10:52 ET
2.09MMarket Cap-0.50P/E (TTM)
0.010High0.005Low102.00KVolume0.010Open0.010Pre Close515.00Turnover0.04052wk High0.03%Turnover Ratio418.56MShares0.00552wk Low-0.01EPS TTM2.06MFloat Cap0.960Historical HighLossP/E (Static)411.61MShs Float0.005Historical Low-0.01EPS LYR50.00%Amplitude--Dividend TTM0.31P/B1Lot Size--Div YieldTTM
Revive Therapeutics Ltd Key Stats
Quarterly+Annual
YOY
| (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 5.14%-470.07K | 45.39%-3.29M | 51.36%-276.33K | 24.18%-1.64M | -0.81%-883.42K | 79.56%-495.53K | 53.86%-6.03M | 63.10%-568.09K | 47.13%-2.16M | 84.42%-876.31K |
| Net income from continuing operations | -20.96%-472.51K | 11.11%-5.62M | -116.80%-2.59M | 3.71%-1.87M | 49.47%-770.62K | 76.46%-390.62K | 64.50%-6.32M | 57.64%-1.19M | 67.72%-1.94M | 62.79%-1.52M |
| Operating gains losses | -165.33%-833 | 11,968.55%194.55K | 1,612.82%20.18K | 348,956.00%174.43K | -80.22%-1.34K | -65.90%1.28K | -94.43%1.61K | -104.68%-1.33K | 93.97%-50 | -158.89%-743 |
| Depreciation and amortization | -24.39%62 | -24.42%328 | -24.77%82 | -24.07%82 | -24.77%82 | -24.07%82 | -24.91%434 | -24.83%109 | -25.00%108 | -24.83%109 |
| Asset impairment expenditure | ---- | 201.75%2.34M | ---- | ---- | ---- | ---- | --777K | ---- | ---- | ---- |
| Unrealized gains and losses of investment securities | --6.03K | -267.18%-146.28K | -88.52%10.05K | ---- | ---- | --0 | --87.5K | --87.5K | ---- | ---- |
| Remuneration paid in stock | ---- | --136.45K | --0 | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Other non cashItems | -34.67%556 | -109.25%-16.31K | -7,691.46%-64K | -96.58%5.95K | 5,816.64%40.88K | 22.27%851 | 27.33%176.25K | -99.13%843 | 25,083.07%174.02K | -98.30%691 |
| Change In working capital | 96.85%-3.37K | 75.18%-185.54K | 99.24%-1.83K | 119.59%75.82K | -123.50%-152.42K | 86.08%-107.11K | -121.11%-747.61K | -120.82%-239.65K | -119.92%-387.07K | 127.21%648.58K |
| -Change in receivables | -211.52%-4.65K | -82.17%10.65K | 62.92%57.85K | 30.94%-13.83K | -474.21%-31.88K | -103.00%-1.49K | 232.15%59.74K | 183.33%35.51K | -3.49%-20.03K | -114.90%-5.55K |
| -Change in prepaid assets | 210.38%60.14K | -83,436.36%-238.91K | -1,461.17%-219.41K | 9.11%17.39K | -16.14%17.59K | -2.19%-54.49K | -102.64%-286 | -0.20%16.12K | -16.70%15.94K | 49.57%20.97K |
| -Change in payables and accrued expense | -73.79%-88.86K | 105.64%42.73K | 154.84%159.73K | 118.87%72.26K | -121.82%-138.13K | 92.86%-51.13K | -121.17%-757.06K | -124.74%-291.28K | -119.71%-382.98K | 126.00%633.17K |
| -Change in other working capital | --30K | ---- | ---- | ---- | ---- | ---- | ---50K | --0 | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 5.14%-470.07K | 45.39%-3.29M | 51.36%-276.33K | 24.18%-1.64M | -0.81%-883.42K | 79.56%-495.53K | 53.86%-6.03M | 63.10%-568.09K | 47.13%-2.16M | 84.42%-876.31K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -30K | 0 | ||||||||
| Net investment purchase and sale | ---30K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---30K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | -52.91%1.98M | -40K | -50.84%2.02M | 0 | 0 | 1,015.32%4.2M | 0 | 5,919.42%4.1M | 0 |
| Net issuance payments of debt | --0 | ---40K | ---40K | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net common stock issuance | ---- | -48.38%2.02M | --0 | ---- | ---- | ---- | 938.50%3.91M | -177.42%-291.2K | ---- | ---- |
| Proceeds from stock option exercised by employees | ---- | --0 | ---- | ---- | ---- | ---- | --291.2K | ---- | ---- | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | -52.91%1.98M | ---40K | -50.84%2.02M | --0 | --0 | 1,015.32%4.2M | --0 | 5,919.42%4.1M | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -62.96%773.07K | -46.69%2.09M | -60.48%1.05M | -0.25%708.42K | 0.34%1.59M | -46.69%2.09M | -76.41%3.92M | -49.77%2.66M | -92.36%710.17K | -89.29%1.59M |
| Current changes in cash | -0.92%-500.07K | 28.11%-1.31M | 51.36%-276.33K | -82.47%340.98K | -0.81%-883.42K | 78.72%-495.53K | 85.59%-1.83M | 58.57%-568.09K | 148.49%1.95M | 84.12%-876.31K |
| End cash Position | -82.85%273K | -62.96%773.07K | -62.96%773.07K | -60.48%1.05M | -0.25%708.42K | 0.34%1.59M | -46.69%2.09M | -46.69%2.09M | -49.77%2.66M | -92.36%710.17K |
| Free cash from | 5.14%-470.07K | 45.39%-3.29M | 51.36%-276.33K | 24.18%-1.64M | -0.81%-883.42K | 79.56%-495.53K | 53.86%-6.03M | 63.10%-568.09K | 47.13%-2.16M | 84.42%-876.31K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Price
% Chg
No Data